SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001181431-12-054549
Filing Date
2012-10-12
Accepted
2012-10-12 08:12:42
Documents
2
Period of Report
2012-10-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 rrd358170.html 3  
1 FORM 3 rrd358170.xml 3 3361
2 POWER OF ATTORNEY rrd321428_363368.htm EX-24. 1542
  Complete submission text file 0001181431-12-054549.txt   7321
Mailing Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD
Business Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD 011 44 20 7304 5000
ASTRAZENECA PLC (Reporting) CIK: 0000901832 (see all company filings)

Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35670 | Film No.: 121141052
SIC: 2834 Pharmaceutical Preparations

Mailing Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85
Business Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85 0044 (0) 20 7604 800
ASTRAZENECA AB (Reporting) CIK: 0000928966 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-35670 | Film No.: 121141051

Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations